Candel Therapeutics (CADL) Depreciation and Depletion (2022 - 2025)

Candel Therapeutics has disclosed Depreciation and Depletion across 4 years of filings, most recently posting $100000.0 for Q4 2025.

• Depreciation and Depletion for Q4 2025 came in at $100000.0, down 66.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $745000.0 (down 25.5% YoY), and the FY2025 annual result was $800000.0, down 20.0% from the prior year.
• Depreciation and Depletion came in at $100000.0 for Q4 2025 at Candel Therapeutics, down from $200000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $300000.0 in Q4 2023 to a low of $100000.0 in Q4 2025.
• The 4-year median for Depreciation and Depletion is $200000.0 (2023), against an average of $222153.8.
• Across the five-year window, Depreciation and Depletion jumped 50.0% in 2024 and sank 66.67% in 2025, its largest moves.
• Candel Therapeutics' Depreciation and Depletion stood at $243000.0 in 2022, then gained by 23.46% to $300000.0 in 2023, then changed by 0.0% to $300000.0 in 2024, then slumped by 66.67% to $100000.0 in 2025.
• The last three Depreciation and Depletion figures came in at $100000.0 (Q4 2025), $200000.0 (Q3 2025), and $200000.0 (Q2 2025), per Business Quant data.